Human Gene Transfer Research and Institutional Biosafety Committees (IBCs): An Introduction

Thursday, March 30
Presentation: 3:00-4:00pm ET
Q&A: 4:00-4:15pm ET

Research involving human gene transfer and recombinant DNA is on the rise, and it’s likely to continue to grow, particularly in the field of oncology. For human gene transfer studies receiving federal funds or taking place at sites receiving federal funds, federal requirements call for review by both an IRB and an IBC prior to registering with the National Institutes of Health (NIH). Further review may be required by the NIH Recombinant DNA Advisory Committee (RAC).

In this webinar, Schulman IRB’s Biosafety Officer Daniel Eisenman will discuss the IBC’s role in ensuring research involving genetic engineering is conducted safely and responsibly.

Presentation Objectives
In this free webinar, we will:

  • Define the federal requirements and oversight structure governing research involving recombinant DNA and gene transfer
  • Explain the role and functions of the IBC
  • Describe types of studies which might require IBC review

Who Should Attend: Representatives from sponsors, CROs and study sites seeking an introduction to the science and regulatory oversight of research involving the delivery of modified genetic material to study participants.

Certificates of attendance are available for this event. This presentation may qualify for continuing education credits; check with your certifying organization(s) for more information.

Registration for this webinar has ended.
Please visit for more information on Schulman's webinar series.